Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220009060 220003661 1.77 14.4 Palliative (P) 2016-06-12 2016-06-17 CABOZANTINIB N N 220035800 CISPLATIN + ETOPOSIDE
220009061 220003662 2 79.9 Curative (C) 2016-07-10 2016-07-10 CISPLATIN + DOCETAXEL + FLUOROURACIL 2 N 220035811 ATG + BUSULFAN + FLUDARABINE
220009062 220003663 null 76 Adjuvant (A) 2013-08-10 2013-08-10 CETUXIMAB null null 220035815 BEVACIZUMAB
220009063 220003664 1.77 0 Palliative (P) null 2015-03-01 BOSUTINIB N N 220035816 CAPECITABINE + STREPTOZOCIN
220009064 220003665 null null Palliative (P) 2016-03-18 2016-03-26 ECarboX null null 220035828 VINCRISTINE
220009065 220003666 1.65 52 null 2016-07-13 2016-07-26 RUXOLITINIB 02 N 220035832 INTERFERON
220009066 220003667 1.8 59.7 Palliative (P) 2013-08-04 2013-08-04 Triple / Double Intrathecal Therapy N N 220035834 CAPECITABINE + STREPTOZOCIN
220009067 220003668 1.56 74.6 Palliative (P) 2015-04-01 2015-06-28 Y-90 N null 220035837 CHOP R
220009068 220003669 1.74 null Palliative (P) 2015-09-02 2015-09-28 Methotrexate intrathecal N N 220035839 CETUXIMAB
220009069 220003670 1.73 null Palliative (P) 2015-12-05 2015-12-11 VINCRISTINE N N 220035840 DOXORUBICIN
220009070 220011989 null null Palliative (P) 2013-03-15 2013-03-15 Cyclophosphamide TBI Allograft Y N 220035843 DACARBAZINE
220009071 220011989 1.68 111 Palliative (P) null 2018-09-01 CYCLOPHOSPHAMIDE + FLUDARABINE N N 220035843 CISPLATIN + DOCETAXEL + FLUOROURACIL
220009072 220011989 0 null Curative (C) 2013-10-02 2013-10-10 Irinotecan + Modified De Gramont N Y 220035843 TRIPLE INTRATHECAL
220009073 220011989 1.61 74.8 Palliative (P) null 2016-12-19 Melphalan IV High dose N N 220035843 VINCRISTINE
220009074 220011989 1.6 -1 Palliative (P) 2013-08-29 2013-08-29 Capecitabine 02 N 220035843 CAPECITABINE
220009075 220011989 1.76 0 Neo-adjuvant (N) 2014-07-13 2014-07-19 AML LI-1 Trial N N 220035843 FEC
220009076 220003671 1.48 null Curative (C) 2017-08-08 2017-09-08 UKALL14- Ph 1 Induction N N 220035856 ARSENIC TRIOXIDE
220009077 220003672 1.74 51.1 Palliative (P) 2014-03-09 2014-03-18 UKALL14- Ph 1 Induction N N 220035858 CYTARABINE INTRATHECAL
220009079 220011990 null 92.6 Adjuvant (A) 2013-08-09 2013-08-09 Cisplatin 2 null 220035861 CARBOPLATIN + RT
220009080 220003674 1.58 20.9 Disease modification (D) 2015-08-05 2015-08-05 FLUOROURACIL + FOLINIC ACID 01 N 220035866 LI-1 TRIAL
220009081 220003675 1.85 null Curative (C) 2015-01-29 2015-01-30 Thalidomide 50mg N N 220035867 FIGARO TRIAL
220009082 220011991 1.77 93 Curative (C) 2019-02-20 2019-02-21 Vemurafenib 01 N 220035870 CVP R
220009083 220011991 1.55 76.6 Curative (C) 2017-04-24 2017-05-15 IDARUBICIN + MITOXANTRONE + Tretinoin 02 N 220035870 FLA
220009084 220003676 1.68 88.8 Palliative (P) 2014-10-18 2014-10-20 Alemtuzumab(INTRAVENOUS) 02 N 220035874 RUXOLITINIB
220009085 220003676 1.71 65 Palliative (P) 2014-05-22 2014-05-24 Sunitinib N N 220035874 DABRAFENIB + TRAMETINIB
220009086 220003677 null 49.1 Curative (C) 2015-02-11 2015-02-11 Alemtuzumab cond (RI ALLO CAMP100) N N 220035878 FBC
220009087 220003677 null 77.1 Palliative (P) 2014-10-13 2014-10-17 SPIRIT 2 TRIAL N null 220035878 CISPLATIN + FLUOROURACIL
220009088 220003677 1.7 77 Palliative (P) 2016-02-16 2016-02-17 Cisplatin + Etoposide (3 day) 02 null 220035878 CETUXIMAB + IRINOTECAN + MDG
220009089 220003678 null 60.5 Not known (9) 2013-09-12 2013-09-12 Melphalan oral 02 Y 220035885 UKALL2014
220009090 220003678 1.73 95 Palliative (P) 2013-11-21 2013-12-01 Cyclophosphamide High Dose N N 220035885 FLUOROURACIL + IRINOTECAN + OXALIPLATIN
220009091 220003679 null null Palliative (P) 2013-02-25 2013-02-26 PACLITAXEL null null 220035892 PACLITAXEL
220009092 220003679 null 84 null 2015-01-08 2015-01-08 Bevacizumab+Carbo+Pacliaxel 02 Y 220035892 UKALL XII
220009093 220003680 0 68 Curative (C) 2016-02-27 2016-02-27 Folfirinox 02 N 220035898 SPIRIT TRIAL
220009094 220003680 null 92.3 Palliative (P) 2015-12-30 2015-12-30 Doxorubicin 75mg/m2 null N 220035898 IPILIMUMAB
220009095 220003680 null 69.9 Palliative (P) 2016-10-03 2016-11-11 Paclitaxel 7 day N N 220035898 PEMETREXED
220009096 220003680 1.75 null Neo-adjuvant (N) 2015-11-03 2015-11-04 IDARUBICIN N N 220035898 CISPLATIN + DOCETAXEL + FLUOROURACIL
220009097 220003681 0 96 Palliative (P) 2014-06-26 2014-07-03 BOSUTINIB N N 220035911 IRINOTECAN + MDG
220009098 220003681 null null null 2014-11-23 2014-12-24 Abiraterone N N 220035911 CISPLATIN + PEMETREXED
220009099 220003681 1.79 null Adjuvant (A) 2016-06-09 2016-06-09 CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB 99 N 220035911 LANREOTIDE
220009100 220003681 1.66 75.1 Palliative (P) 2014-04-15 2014-04-16 CAPECITABINE + CARBOPLATIN 2 null 220035911 IPILIMUMAB
220009101 220003681 1.52 63 Palliative (P) 2016-11-12 2016-12-06 CVP R N N 220035911 LI-1 TRIAL
220009102 220003682 null 78.6 Palliative (P) 2017-11-19 2017-11-19 BOSUTINIB 2 null 220035924 CAPECITABINE + CISPLATIN
220009103 220003682 0.62 null null 2014-04-28 2014-05-01 Cyclophosphamide High Dose N N 220035924 CAPECITABINE
220009104 220003682 1.9 88.9 Palliative (P) 2015-08-27 2016-08-04 DABRAFENIB + TRAMETINIB N N 220035924 DABRAFENIB + TRAMETINIB
220009105 220019049 1.55 47.6 Palliative (P) 2015-02-15 2015-02-15 UKALL14- Ph 1 Induction N N 220035938 CYTARABINE INTRATHECAL
220009106 220019049 1.66 79 Palliative (P) 2015-03-27 2015-03-29 Cisplatin +Fluorouracil (3 wk) 02 N 220035938 CAPECITABINE + CISPLATIN
220009107 220019049 1.73 88.6 Neo-adjuvant (N) null 2013-08-14 Ipilimumab N N 220035938 BENDAMUSTINE + THALIDOMIDE
220009108 220019049 null null Disease modification (D) null 2016-01-03 Fludarabine + Melphalan RIC Allo Y N 220035938 BORTEZOMIB
220009109 220021786 1.73 null Palliative (P) 2016-05-02 2016-05-07 CISPLATIN + ETOPOSIDE 2 Y 220035947 CARBO + FLUOROURACIL
220009110 220021786 null null Palliative (P) 2016-03-10 2016-03-16 PACLITAXEL null null 220035947 CISPLATIN + FLUOROURACIL